Paget's disease of the breast differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 97: | Line 97: | ||
* [[Biopsy]] | * [[Biopsy]] | ||
* Immunohistochemical stain for | * Immunohistochemical stain for Anti[[interleukin]]: | ||
:*[[Interleukin 4|IL-4]] | |||
:*Anti-[[Interleukin 13|IL-13]] | :*Anti-[[Interleukin 13|IL-13]] | ||
:*Anti-[[CD4]] | :*Anti-[[CD4]] | ||
Line 114: | Line 114: | ||
* [[Benign]] | * [[Benign]] | ||
* Neoplasm of breast lactiferous ducts | * Neoplasm of breast lactiferous ducts | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Proliferation]] of the inner [[Epithelial|epithelial layer]] and outer, [[basal layer]] of [[myoepithelial cells]] of the [[Lactiferous duct|lactiferous ducts]] the [[nipple]]. | * [[Proliferation]] of the inner [[Epithelial|epithelial layer]] and outer, [[basal layer]] of [[myoepithelial cells]] of the [[Lactiferous duct|lactiferous ducts]] the [[nipple]]. | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Eczema]], crusts or erosion of nipple | ||
| align=" | | align="left" style="background:#F5F5F5;" |Serous or bloody [[nipple discharge]]. | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Nipple]] may have unencapsulated, firm [[Granuloma|granulomatous lesion]] . | * [[Nipple]] may have unencapsulated, firm [[Granuloma|granulomatous lesion]] . | ||
* A non-tender [[nodule]] either within or under the [[nipple]] adherent to the [[skin]], but not the [[breast]] may be palpated. | * A non-tender [[nodule]] either within or under the [[nipple]] adherent to the [[skin]], but not the [[breast]] may be palpated. | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Insidious onset. | * Insidious onset. | ||
* [[Erythema]] may be seen prior to [[erosion]]. | * [[Erythema]] may be seen prior to [[erosion]]. | ||
* No [[lymphadenopathy]]. | * No [[lymphadenopathy]]. | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Overlying epidermis often shows [[acanthosis]] and [[hyperkeratosis]]. | * Overlying epidermis often shows [[acanthosis]] and [[hyperkeratosis]]. | ||
* Papillomatous pattern: [[vascular]] papillae project into dilated [[lumina]] and are surrounded by [[Epithelial cells|proliferating epithelial cells]] . | * Papillomatous pattern: [[vascular]] papillae project into dilated [[lumina]] and are surrounded by [[Epithelial cells|proliferating epithelial cells]] . | ||
* [[Papilla|Papillary]] pattern: [[cells]] proliferate into large cords with deep fissures and clefts and dense [[stroma]]. | * [[Papilla|Papillary]] pattern: [[cells]] proliferate into large cords with deep fissures and clefts and dense [[stroma]]. | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Biopsy]]: Shows absence of [[Atypia|cytological atypia]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Incidence]] is highest in the fifth decade in women. | * [[Incidence]] is highest in the fifth decade in women. | ||
* No [[lymphadenopathy]]. | * No [[lymphadenopathy]]. | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Benign]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Delayed-type [[hypersensitivity]] response | * Delayed-type [[hypersensitivity]] response | ||
* Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | * Skin [[inflammation]] mediated by [[Haptens|hapten]]-specific T cells | ||
| align=" | | align="left" style="background:#F5F5F5;" | Erythematous well-demarcated [[papules]] | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |N/A | | align="center" style="background:#F5F5F5;" |N/A | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Stinging and burning | * Stinging and burning | ||
* Localized [[swelling]] | * Localized [[swelling]] | ||
* [[Lichenification|Lichenified]] [[Itch|pruritic]] [[plaques]] | * [[Lichenification|Lichenified]] [[Itch|pruritic]] [[plaques]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Eosinophilic]] spongiosis and [[microvesicles]] | * [[Eosinophilic]] spongiosis and [[microvesicles]] | ||
* [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]] | * [[Exocytosis]] of [[eosinophils]] and [[lymphocytes]] | ||
* Chronic - [[Hyperkeratosis]] and [[parakeratosis]] | * Chronic - [[Hyperkeratosis]] and [[parakeratosis]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Clinical examination | * Clinical examination | ||
* [[Biopsy]] | * [[Biopsy]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Contact with [[allergens]] in the past 1-2 days | * Contact with [[allergens]] in the past 1-2 days | ||
Line 166: | Line 162: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]]<ref name="pmid20107724">{{cite journal |vauthors=Ljosaa TM, Rustoen T, Mörk C, Stubhaug A, Miaskowski C, Paul SM, Wahl AK |title=Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics |journal=Acta Derm. Venereol. |volume=90 |issue=1 |pages=39–45 |date=2010 |pmid=20107724 |doi=10.2340/00015555-0764 |url=}}</ref><ref name="pmid1390163">{{cite journal |vauthors=Naldi L, Parazzini F, Brevi A, Peserico A, Veller Fornasa C, Grosso G, Rossi E, Marinaro P, Polenghi MM, Finzi A |title=Family history, smoking habits, alcohol consumption and risk of psoriasis |journal=Br. J. Dermatol. |volume=127 |issue=3 |pages=212–7 |date=September 1992 |pmid=1390163 |doi= |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Psoriasis]]<ref name="pmid20107724">{{cite journal |vauthors=Ljosaa TM, Rustoen T, Mörk C, Stubhaug A, Miaskowski C, Paul SM, Wahl AK |title=Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics |journal=Acta Derm. Venereol. |volume=90 |issue=1 |pages=39–45 |date=2010 |pmid=20107724 |doi=10.2340/00015555-0764 |url=}}</ref><ref name="pmid1390163">{{cite journal |vauthors=Naldi L, Parazzini F, Brevi A, Peserico A, Veller Fornasa C, Grosso G, Rossi E, Marinaro P, Polenghi MM, Finzi A |title=Family history, smoking habits, alcohol consumption and risk of psoriasis |journal=Br. J. Dermatol. |volume=127 |issue=3 |pages=212–7 |date=September 1992 |pmid=1390163 |doi= |url=}}</ref> | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Benign]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Keratinocyte]] hyperproliferation | * [[Keratinocyte]] hyperproliferation | ||
* Dysregulation of the [[immune system]] | * Dysregulation of the [[immune system]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 176: | Line 172: | ||
| align="center" style="background:#F5F5F5;" | N/A | | align="center" style="background:#F5F5F5;" | N/A | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Auspitz's sign]] (pinpoint bleeding) | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Epidermal]] [[hyperplasia]] | * [[Epidermal]] [[hyperplasia]] | ||
* Parakeratosis | * Parakeratosis | ||
* [[Neutrophils]] microabscesses (Munro microabscesses) | * [[Neutrophils]] microabscesses (Munro microabscesses) | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Clinical examination | * Clinical examination | ||
* [[Biopsy]] | * [[Biopsy]] | ||
|Risk factors include | |Risk factors include | ||
Line 194: | Line 189: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Melanoma|Malignant melanoma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Melanoma|Malignant melanoma]] | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Malignant]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Neural crest cell]] derivative | * [[Neural crest cell]] derivative | ||
* Development begins with disruption of [[nevus]] growth control | * Development begins with disruption of [[nevus]] growth control | ||
* Progression involves [[MAPK/ERK pathway]] | * Progression involves [[MAPK/ERK pathway]] | ||
* [[RAS|N-RAS]] or [[BRAF]] [[oncogene]]<nowiki/>also involved | * [[RAS|N-RAS]] or [[BRAF]] [[oncogene]]<nowiki/>also involved | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Macule | * Macule | ||
* Plaque with irregular border | * Plaque with irregular border | ||
Line 215: | Line 210: | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |N/A | | align="center" style="background:#F5F5F5;" |N/A | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Pigmented lesion with: | * Pigmented lesion with: | ||
* Asymmetry | * Asymmetry | ||
* Irregular borders | * Irregular borders | ||
* Variegated color | * Variegated color | ||
* Diameter >6 mm | * Diameter >6 mm | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Nests of atypical melanocytes with asymmetry, poor circumscription of varying sizes and shapes | * Nests of atypical melanocytes with asymmetry, poor circumscription of varying sizes and shapes | ||
* Present in the lower epidermis and dermis | * Present in the lower epidermis and dermis | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Complete full-thickness excisional [[biopsy]] of suspicious lesions with 1 to 3 mm margin of normal skin. | * Complete full-thickness excisional [[biopsy]] of suspicious lesions with 1 to 3 mm margin of normal skin. | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
Line 236: | Line 230: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bowen’s disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bowen’s disease]] | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Benign]] can turn [[malignant]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Solar damage | * Solar damage | ||
* [[Arsenic]] | * [[Arsenic]] | ||
Line 243: | Line 237: | ||
* [[Viral]] [[infection]] ([[human papillomavirus]] or [[HPV]]) | * [[Viral]] [[infection]] ([[human papillomavirus]] or [[HPV]]) | ||
* [[Skin disease|Dermatoses]] | * [[Skin disease|Dermatoses]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Erythema|Erythematous]] | * [[Erythema|Erythematous]] | ||
* Skin colored | * Skin colored | ||
* Patch | * Patch | ||
* Plaque | * Plaque | ||
Line 255: | Line 248: | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |N/A | | align="center" style="background:#F5F5F5;" |N/A | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Presence of dotted and/or glomerular vessels | * Presence of dotted and/or glomerular vessels | ||
* White to yellowish surface scales | * White to yellowish surface scales | ||
* Red-yellowish background | * Red-yellowish background | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Keratinocytic dysplasia of the | * Keratinocytic dysplasia of the | ||
* | * | ||
Line 266: | Line 259: | ||
* Pleomorphic keratinocytes | * Pleomorphic keratinocytes | ||
* Hyperchromatic nuclei | * Hyperchromatic nuclei | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Clinical examination | * Clinical examination | ||
* [[Biopsy]] | * [[Biopsy]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Slow growth over the years | * Slow growth over the years | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Basal cell carcinoma|Superficial basal cell carcinoma]]<ref name="pmid11668245">{{cite journal |vauthors=Yamamoto H, Ito Y, Hayashi T, Urano N, Kato T, Kimura Y, Tanigawa T, Endo W, Kurokawa E, Kikkawa N, Taniguchi H |title=A case of basal cell carcinoma of the nipple and areola with intraductal spread |journal=Breast Cancer |volume=8 |issue=3 |pages=229–33 |date=2001 |pmid=11668245 |doi= |url=}}</ref><ref name="pmid30057838">{{cite journal |vauthors=Ulanja MB, Taha ME, Al-Mashhadani AA, Al-Tekreeti MM, Elliot C, Ambika S |title=Basal Cell Carcinoma of the Female Breast Masquerading as Invasive Primary Breast Carcinoma: An Uncommon Presentation Site |journal=Case Rep Oncol Med |volume=2018 |issue= |pages=5302185 |date=2018 |pmid=30057838 |pmc=6051126 |doi=10.1155/2018/5302185 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Basal cell carcinoma|Superficial basal cell carcinoma]]<ref name="pmid11668245">{{cite journal |vauthors=Yamamoto H, Ito Y, Hayashi T, Urano N, Kato T, Kimura Y, Tanigawa T, Endo W, Kurokawa E, Kikkawa N, Taniguchi H |title=A case of basal cell carcinoma of the nipple and areola with intraductal spread |journal=Breast Cancer |volume=8 |issue=3 |pages=229–33 |date=2001 |pmid=11668245 |doi= |url=}}</ref><ref name="pmid30057838">{{cite journal |vauthors=Ulanja MB, Taha ME, Al-Mashhadani AA, Al-Tekreeti MM, Elliot C, Ambika S |title=Basal Cell Carcinoma of the Female Breast Masquerading as Invasive Primary Breast Carcinoma: An Uncommon Presentation Site |journal=Case Rep Oncol Med |volume=2018 |issue= |pages=5302185 |date=2018 |pmid=30057838 |pmc=6051126 |doi=10.1155/2018/5302185 |url=}}</ref> | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Malignant]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* UV light induces inflammation of the skin. | * UV light induces inflammation of the skin. | ||
* Patched 1 (PTCH1) tumor suppressor gene on chromosome 9 | * Patched 1 (PTCH1) tumor suppressor gene on chromosome 9 | ||
Line 286: | Line 279: | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |N/A | | align="center" style="background:#F5F5F5;" |N/A | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Superficial fine telangiectasia | * Superficial fine telangiectasia | ||
* Shiny white to red, translucent or opaque structureless areas | * Shiny white to red, translucent or opaque structureless areas | ||
* Multiple small erosions | * Multiple small erosions | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Large, hyperchromatic, oval nuclei | * Large, hyperchromatic, oval nuclei | ||
* Minimal cytoplasm | * Minimal cytoplasm | ||
* Small basaloid nodules | * Small basaloid nodules | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Biopsy]] | * [[Biopsy]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 300: | Line 293: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Squamous metaplasia of lactiferous ducts (SMOLD)/ [[Zuska's disease]]<ref name="pmid20610247">{{cite journal |vauthors=Gollapalli V, Liao J, Dudakovic A, Sugg SL, Scott-Conner CE, Weigel RJ |title=Risk factors for development and recurrence of primary breast abscesses |journal=J. Am. Coll. Surg. |volume=211 |issue=1 |pages=41–8 |date=July 2010 |pmid=20610247 |doi=10.1016/j.jamcollsurg.2010.04.007 |url=}}</ref><ref name="pmid7570336">{{cite journal |vauthors=Meguid MM, Oler A, Numann PJ, Khan S |title=Pathogenesis-based treatment of recurring subareolar breast abscesses |journal=Surgery |volume=118 |issue=4 |pages=775–82 |date=October 1995 |pmid=7570336 |doi= |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Squamous metaplasia of lactiferous ducts (SMOLD)/ [[Zuska's disease]]<ref name="pmid20610247">{{cite journal |vauthors=Gollapalli V, Liao J, Dudakovic A, Sugg SL, Scott-Conner CE, Weigel RJ |title=Risk factors for development and recurrence of primary breast abscesses |journal=J. Am. Coll. Surg. |volume=211 |issue=1 |pages=41–8 |date=July 2010 |pmid=20610247 |doi=10.1016/j.jamcollsurg.2010.04.007 |url=}}</ref><ref name="pmid7570336">{{cite journal |vauthors=Meguid MM, Oler A, Numann PJ, Khan S |title=Pathogenesis-based treatment of recurring subareolar breast abscesses |journal=Surgery |volume=118 |issue=4 |pages=775–82 |date=October 1995 |pmid=7570336 |doi= |url=}}</ref> | ||
| align=" | | align="left" style="background:#F5F5F5;" |[[Benign]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Keratin]] plug blocking [[lactiferous duct]] leads to [[duct]] rupture and spillage of [[keratin]] debris in [[stroma]] | * [[Keratin]] plug blocking [[lactiferous duct]] leads to [[duct]] rupture and spillage of [[keratin]] debris in [[stroma]] | ||
* Leading to [[chronic inflammation]] with [[giant cells]] surrounding ducts and [[squamous metaplasia]] | * Leading to [[chronic inflammation]] with [[giant cells]] surrounding ducts and [[squamous metaplasia]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Painful [[erythematous]] [[Subareolar abscess|subareolar mass]] | * Painful [[erythematous]] [[Subareolar abscess|subareolar mass]] | ||
* Single [[Fistula|fistula tract]] at the [[Areolar tissue|areolar]] edge. | * Single [[Fistula|fistula tract]] at the [[Areolar tissue|areolar]] edge. | ||
Line 311: | Line 304: | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Tenderness (medicine)|Tender]] [[Erythema|erythematous]], [[Subareolar abscess|subareolar]] [[mass]]. | * [[Tenderness (medicine)|Tender]] [[Erythema|erythematous]], [[Subareolar abscess|subareolar]] [[mass]]. | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Appears as an ill-defined firm area. | * Appears as an ill-defined firm area. | ||
* No associated [[lymphadenopathy]]. | * No associated [[lymphadenopathy]]. | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Squamous epithelium]] extending beyond the normal transition point within the [[Duct carcinoma|duct]] orifice into ductal [[epithelium]]. | * [[Squamous epithelium]] extending beyond the normal transition point within the [[Duct carcinoma|duct]] orifice into ductal [[epithelium]]. | ||
* [[Keratin]] debris can extend into duct spaces. | * [[Keratin]] debris can extend into duct spaces. | ||
* [[Squamous metaplasia]] of the deep [[ducts]] filled with [[keratin]] debris can be seen along with areas of rupture and spillage of [[keratin]] into the surrounding [[stroma]]. | * [[Squamous metaplasia]] of the deep [[ducts]] filled with [[keratin]] debris can be seen along with areas of rupture and spillage of [[keratin]] into the surrounding [[stroma]]. | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* [[Biopsy]] | * [[Biopsy]] | ||
| align=" | | align="left" style="background:#F5F5F5;" | | ||
* Strong association with [[smoking]]. | * Strong association with [[smoking]]. | ||
* [[Tobacco]] exposure or decreased level of [[vitamin A]] secondary to [[smoking]] may cause [[squamous metaplasia]]. | * [[Tobacco]] exposure or decreased level of [[vitamin A]] secondary to [[smoking]] may cause [[squamous metaplasia]]. |
Revision as of 15:15, 27 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Paget's disease of the breast is often misdiagnosed as nipple eczema
Diseases | Benign or Malignant | Etiology | Clinical manifestations | Histopathology | Gold Standard | Associated factors | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||
Rash | Nipple Discharge | Erythema | Mastalgia | Breast Exam | Other | ||||||
Paget's disease of the breast[1][2] | Most the patients have underlying breast cancer. | Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region | + | + | ± |
|
Usually unilateral nipple is effected |
|
| ||
Atopic dermatitis |
|
– | – | – | N/A |
|
|
|
| ||
Erosive adenomatosis of the nipple[5][6] |
|
|
Eczema, crusts or erosion of nipple | Serous or bloody nipple discharge. | + | – |
|
|
Biopsy: Shows absence of cytological atypia |
| |
Allergic contact dermatitis[7] | Benign |
|
Erythematous well-demarcated papules | – | – | + | N/A |
|
|
|
|
Psoriasis[8][9] | Benign |
|
Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | – | + | + | N/A | Auspitz's sign (pinpoint bleeding) |
|
|
Risk factors include
|
Malignant melanoma | Malignant |
|
|
± | – | – | N/A |
|
|
|
|
Bowen’s disease | Benign can turn malignant |
|
|
– | + | – | N/A |
|
|
|
|
Superficial basal cell carcinoma[10][11] | Malignant |
|
|
– | + | – | N/A |
|
|
| |
Squamous metaplasia of lactiferous ducts (SMOLD)/ Zuska's disease[12][13] | Benign |
|
|
– | + | + |
|
|
| ||
Lactiferous duct ectasia / Plasma cell mastitis / Comedomastitis | Benign |
|
Nipple retraction | + | – | – |
|
Thick nipple discharge. |
|
Ultrasound:
|
|
Nipple Adenoma / Papillary adenoma of the nipple | Benign |
|
|
± | + | – |
|
|
|
|
|
Nevoid hyperkeratosis of the nipple and areola (NHNA) [14][15] | Benign |
|
Slow growing bluish-brown verrucous thickening of the nipple or areola. | – | – | – |
|
|
Biopsy |
| |
Benign Toker cell hyperplasia | Benign |
|
Normal nipple- areolar complex | – | – | – | Normal breast examination. | N/A |
|
|
|
Breast abscess | Benign |
|
± | + | + |
|
|
|
|
||
Mondors disease[16][17] | Benign | Superficial phlebitis and periphlebitis of the superficial vein. | Red linear cord running from the lateral margin of the breast attached to the overlying skin. | – | + | + |
|
|
|
| |
Mastitis[18][19] |
|
|
|
± | + | ± |
|
|
History of lactation including difficulty in breastfeeding, breast engorgement, or erosion of nipples. | ||
Inflammatory Breast Cancer[20][21] | Malignant | Cancer cells block the lymphatic vessels in skin covering the breast |
|
– | + | + |
|
|
|
Core needle Biopsy |
|
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Song HS, Jung SE, Kim YC, Lee ES (April 2015). "Nipple eczema, an indicative manifestation of atopic dermatitis? A clinical, histological, and immunohistochemical study". Am J Dermatopathol. 37 (4): 284–8. doi:10.1097/DAD.0000000000000195. PMID 25079201.
- ↑ Barankin B, Gross MS (2004). "Nipple and areolar eczema in the breastfeeding woman". J Cutan Med Surg. 8 (2): 126–30. doi:10.1177/120347540400800209. PMID 15129318.
- ↑ Kumar PK, Thomas J (July 2013). "Erosive adenomatosis of the nipple masquerading as Paget's disease". Indian Dermatol Online J. 4 (3): 239–40. doi:10.4103/2229-5178.115534. PMC 3752489. PMID 23984247.
- ↑ Lewis HM, Ovitz ML, Golitz LE (October 1976). "Erosive adenomatosis of the nipple". Arch Dermatol. 112 (10): 1427–8. PMID 962337.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
- ↑ Ljosaa TM, Rustoen T, Mörk C, Stubhaug A, Miaskowski C, Paul SM, Wahl AK (2010). "Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics". Acta Derm. Venereol. 90 (1): 39–45. doi:10.2340/00015555-0764. PMID 20107724.
- ↑ Naldi L, Parazzini F, Brevi A, Peserico A, Veller Fornasa C, Grosso G, Rossi E, Marinaro P, Polenghi MM, Finzi A (September 1992). "Family history, smoking habits, alcohol consumption and risk of psoriasis". Br. J. Dermatol. 127 (3): 212–7. PMID 1390163.
- ↑ Yamamoto H, Ito Y, Hayashi T, Urano N, Kato T, Kimura Y, Tanigawa T, Endo W, Kurokawa E, Kikkawa N, Taniguchi H (2001). "A case of basal cell carcinoma of the nipple and areola with intraductal spread". Breast Cancer. 8 (3): 229–33. PMID 11668245.
- ↑ Ulanja MB, Taha ME, Al-Mashhadani AA, Al-Tekreeti MM, Elliot C, Ambika S (2018). "Basal Cell Carcinoma of the Female Breast Masquerading as Invasive Primary Breast Carcinoma: An Uncommon Presentation Site". Case Rep Oncol Med. 2018: 5302185. doi:10.1155/2018/5302185. PMC 6051126. PMID 30057838.
- ↑ Gollapalli V, Liao J, Dudakovic A, Sugg SL, Scott-Conner CE, Weigel RJ (July 2010). "Risk factors for development and recurrence of primary breast abscesses". J. Am. Coll. Surg. 211 (1): 41–8. doi:10.1016/j.jamcollsurg.2010.04.007. PMID 20610247.
- ↑ Meguid MM, Oler A, Numann PJ, Khan S (October 1995). "Pathogenesis-based treatment of recurring subareolar breast abscesses". Surgery. 118 (4): 775–82. PMID 7570336.
- ↑ Mazzella C, Costa C, Fabbrocini G, Marangi GF, Russo D, Merolla F, Scalvenzi M (November 2016). "Nevoid hyperkeratosis of the nipple mimicking a pigmented basal cell carcinoma". JAAD Case Rep. 2 (6): 500–501. doi:10.1016/j.jdcr.2016.09.007. PMC 5161776. PMID 28004028.
- ↑ Ghanadan A, Balighi K, Khezri S, Kamyabhesari K (September 2013). "Nevoid Hyperkeratosis of the Nipple and/or Areola: Treatment with Topical Steroid". Indian J Dermatol. 58 (5): 408. doi:10.4103/0019-5154.117347. PMC 3778809. PMID 24082214.
- ↑ Hokama A, Fujita J (November 2010). "Mondor disease: an unusual cause of chest pain". South. Med. J. 103 (11): 1189. doi:10.1097/SMJ.0b013e3181ecfcf3. PMID 20890261.
- ↑ Shetty MK, Watson AB (October 2001). "Mondor's disease of the breast: sonographic and mammographic findings". AJR Am J Roentgenol. 177 (4): 893–6. doi:10.2214/ajr.177.4.1770893. PMID 11566698.
- ↑ Kvist LJ, Larsson BW, Hall-Lord ML, Steen A, Schalén C (April 2008). "The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment". Int Breastfeed J. 3: 6. doi:10.1186/1746-4358-3-6. PMC 2322959. PMID 18394188.
- ↑ Foxman B, D'Arcy H, Gillespie B, Bobo JK, Schwartz K (January 2002). "Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States". Am. J. Epidemiol. 155 (2): 103–14. PMID 11790672.
- ↑ Matro JM, Li T, Cristofanilli M, Hughes ME, Ottesen RA, Weeks JC, Wong YN (February 2015). "Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome". Clin. Breast Cancer. 15 (1): 1–7. doi:10.1016/j.clbc.2014.05.005. PMC 4422394. PMID 25034439.
- ↑ Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M (March 2011). "International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment". Ann. Oncol. 22 (3): 515–23. doi:10.1093/annonc/mdq345. PMC 3105293. PMID 20603440.